ct3
ct3 develops wearable real-time biosensors for non-invasive cancer detection. Our technology detects circulating tumor DNA (ctDNA) using microfluidic systems. By enabling continuous, low-cost cancer screening without the need for lab processing, ct3 aims to make early detection accessible, scalable, and patient-friendly.
Contact: ct3.detections@gmail.com